HemoCD as a Totally Synthetic Artificial Oxygen Carrier: Improvements in the Synthesis and O2/CO Discrimination

HemoCD, which is composed of an iron(II)porphyrin such as 5,10,15,20‐tetrakis(4‐sulfonatophenyl)porphinatoiron(II) (Fe(II)TPPS) and a cyclodextrin (CD) dimer having a pyridine linker, represents a synthetic hemoglobin (Hb) model compound that exhibits reversible oxygen (O2) binding ability in aqueou...

Full description

Saved in:
Bibliographic Details
Published inArtificial organs Vol. 41; no. 4; pp. 372 - 380
Main Authors Kitagishi, Hiroaki, Mao, Qiyue, Kitamura, Naoya, Kita, Takahiro
Format Journal Article
LanguageEnglish
Published Geesthacht Wiley Subscription Services, Inc 01.04.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:HemoCD, which is composed of an iron(II)porphyrin such as 5,10,15,20‐tetrakis(4‐sulfonatophenyl)porphinatoiron(II) (Fe(II)TPPS) and a cyclodextrin (CD) dimer having a pyridine linker, represents a synthetic hemoglobin (Hb) model compound that exhibits reversible oxygen (O2) binding ability in aqueous solution at an ambient temperature. Therefore, hemoCD has the potential to be used as a totally synthetic artificial oxygen carrier. In this article, we describe the improvements of hemoCD related to its synthesis and O2/CO selectivity. The synthesis procedure of the CD dimer of hemoCD was re‐examined, and the CD dimer was successively synthesized from inexpensive β‐CD with a 38% yield (three‐steps), which enabled us to obtain the CD dimer in gram‐quantities. The O2/CO selectivity of hemoCD was also markedly improved using an iron(II)porphyrin having a carboxylate group at the distal site of hemoCD.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0160-564X
1525-1594
DOI:10.1111/aor.12870